Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$970M |
| 2 |
AbbVie
ABBV
|
+$554M |
| 3 |
IBM
IBM
|
+$535M |
| 4 |
TC Energy
TRP
|
+$489M |
| 5 |
McKesson
MCK
|
+$459M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.32B |
| 2 |
MON
Monsanto Co
MON
|
+$1.1B |
| 3 |
Kinder Morgan
KMI
|
+$684M |
| 4 |
Amgen
AMGN
|
+$670M |
| 5 |
Danaher
DHR
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.92% |
| 2 | Technology | 12.36% |
| 3 | Communication Services | 10.31% |
| 4 | Consumer Discretionary | 10.04% |
| 5 | Energy | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCH
376
Dauch Corp
DCH
$1.59B
| $12.2M | ﹤0.01% |
707,000
| – | – |
|
|
CCP
377
DELISTED
Care Capital Properties, Inc.
CCP
| $11.9M | ﹤0.01% |
417,750
| – | – |
|
378
Fox Factory Holding Corp
FOXF
$923M
| $11.9M | ﹤0.01% |
+516,000
| New | +$10.2M |
|
379
Vail Resorts
MTN
$5.25B
| $11.8M | ﹤0.01% |
75,000
| – | – |
|
380
M&T Bank
MTB
$36.9B
| $11.6M | ﹤0.01% |
+100,217
| New | +$11.6M |
|
|
EXA
381
DELISTED
EXA Corporation
EXA
| $11.6M | ﹤0.01% |
720,000
| – | – |
|
|
PACW
382
DELISTED
PacWest Bancorp
PACW
| $11.2M | ﹤0.01% |
261,342
| – | – |
|
|
EXAS
383
DELISTED
Exact Sciences
EXAS
| $11M | ﹤0.01% |
592,020
-455,980
| -44% | -$8.04M |
|
|
CAB
384
DELISTED
Cabela's Inc
CAB
| $10.3M | ﹤0.01% |
187,800
-194,700
| -51% | -$9.96M |
|
|
RSPP
385
DELISTED
RSP Permian, Inc.
RSPP
| $9.61M | ﹤0.01% |
+247,800
| New | +$9.16M |
|
386
Devon Energy
DVN
$48.2B
| $8.82M | ﹤0.01% |
200,000
| – | – |
|
387
Bankunited
BKU
$3.42B
| $8.22M | ﹤0.01% |
272,200
-70,800
| -21% | -$2.17M |
|
|
NIHD
388
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $8.21M | ﹤0.01% |
2,464,163
| – | – |
|
389
ENI
E
$78.1B
| $7.31M | ﹤0.01% |
253,148
| – | – |
|
390
RH
RH
$3.52B
| $6.85M | ﹤0.01% |
198,000
| – | – |
|
|
XXIA
391
DELISTED
Ixia
XXIA
| $6.71M | ﹤0.01% |
536,960
-134,240
| -20% | -$1.54M |
|
392
Rogers Communications
RCI
$19.6B
| $5.95M | ﹤0.01% |
140,300
| – | – |
|
|
FRSH
393
DELISTED
Papa Murphy's Holdings, Inc
FRSH
| $5.16M | ﹤0.01% |
800,000
-402,000
| -33% | -$2.58M |
|
394
Lennar Class A
LEN
$21B
| $4.23M | ﹤0.01% |
105,056
| – | – |
|
|
EMBJ
395
Embraer S.A. ADS
EMBJ
$13.2B
| $3.79M | ﹤0.01% |
+219,432
| New | +$4.22M |
|
|
ZX
396
DELISTED
China Zenix Auto Internatl Ltd
ZX
| $3.17M | ﹤0.01% |
2,580,500
| – | – |
|
397
ICICI Bank
IBN
$106B
| $3.01M | ﹤0.01% |
443,267
+1,287
| +0.3% | +$8.97K |
|
398
Banco Bilbao Vizcaya Argentaria
BBVA
$159B
| $1.98M | ﹤0.01% |
338,763
| – | – |
|
|
MESO
399
Mesoblast
MESO
$2.15B
| $1.95M | ﹤0.01% |
226,400
| – | – |
|
400
Lam Research
LRCX
$415B
| $947K | ﹤0.01% |
100,000
| – | – |
|
Similar funds
Capital Research Global Investors's Q3 2016 Portfolio in Review
As of Q3 2016, Capital Research Global Investors held 443 positions worth $303B, up 3.4% from $292B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors's Q3 2016 filing shows 24 new, 126 increased, 140 reduced and 30 closed positions. Its largest new stake was TC Energy: 10,475,000 shares worth $498M. The largest sale was Alexion Pharmaceuticals, an estimated $1.32B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q3 2016 buy was TC Energy: 10,475,000 shares worth $498M.
- Capital Research Global Investors added most to ExxonMobil in Q3 2016, an estimated $970M increase.
- Capital Research Global Investors's biggest Q3 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.32B.
- Capital Research Global Investors fully exited Waste Management in Q3 2016, selling an estimated $637M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $303B portfolio in Q3 2016.
- Capital Research Global Investors opened 24 new positions and closed 30 in Q3 2016.
- Capital Research Global Investors's portfolio value rose 3.4% quarter-over-quarter to $303B.
Based on Capital Research Global Investors's 13F filing for Q3 2016, filed 14 Nov 2016.